Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brit Mollenhauer

Showing results (211-220 of 304) with videos related to

Pageof 31
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseThomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Brain : a Journal of Neurology|May 8, 2020
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primatesMarie-Laure Arotcarena, Sandra Dovero, Alice Prigent, et al.
Journal of Parkinson'S Disease|July 31, 2025
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's diseaseKayenat Parveen, J Alexander Ross, Hendrik van der Wurp, et al.
Movement Disorders Clinical Practice|November 19, 2024
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based StudyPhilipp Mahlknecht, Simon Leiter, Corinne Horlings, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmiaDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Scientific Reports|January 26, 2022
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson's disease patientsElisa Zago, Alessandra Dal Molin, Giovanna Maria Dimitri, et al.
Neurology|December 24, 2013
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD studyAlison J Yarnall, David P Breen, Gordon W Duncan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2020
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's DiseaseFranziska Hopfner, Stefanie H Mueller, Silke Szymczak, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficitsNorbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Journal of Neurochemistry|August 21, 2018
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin studyBrit Mollenhauer, Frederick DuBois Bowman, Daniel Drake, et al.
Pageof 31

Showing results (211-220 of 304) with videos related to

Sort By:
Pageof 31
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseThomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Brain : a Journal of Neurology|May 8, 2020
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primatesMarie-Laure Arotcarena, Sandra Dovero, Alice Prigent, et al.
Journal of Parkinson'S Disease|July 31, 2025
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's diseaseKayenat Parveen, J Alexander Ross, Hendrik van der Wurp, et al.
Movement Disorders Clinical Practice|November 19, 2024
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based StudyPhilipp Mahlknecht, Simon Leiter, Corinne Horlings, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmiaDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Scientific Reports|January 26, 2022
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson's disease patientsElisa Zago, Alessandra Dal Molin, Giovanna Maria Dimitri, et al.
Neurology|December 24, 2013
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD studyAlison J Yarnall, David P Breen, Gordon W Duncan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2020
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's DiseaseFranziska Hopfner, Stefanie H Mueller, Silke Szymczak, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficitsNorbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Journal of Neurochemistry|August 21, 2018
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin studyBrit Mollenhauer, Frederick DuBois Bowman, Daniel Drake, et al.
Pageof 31